Loading...

Athens Medical Center

ATSE:IATR
Snowflake Description

Solid track record and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
IATR
ATSE
€198M
Market Cap
  1. Home
  2. GR
  3. Healthcare
Company description

Athens Medical Center S.A., together with its subsidiaries, owns and operates hospital units in Greece and Romania. The last earnings update was 62 days ago. More info.


Add to Portfolio Compare Print
  • Athens Medical Center has significant price volatility in the past 3 months.
IATR Share Price and Events
7 Day Returns
22.6%
ATSE:IATR
-1.7%
Europe Healthcare
0.3%
GR Market
1 Year Returns
75.4%
ATSE:IATR
-20.9%
Europe Healthcare
4.6%
GR Market
IATR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Athens Medical Center (IATR) 22.6% 26.7% 34.9% 75.4% 204.4% 195.3%
Europe Healthcare -1.7% 0.3% -0.2% -20.9% -10.3% 42.5%
GR Market 0.3% 8% 14.9% 4.6% 43.5% -82.8%
1 Year Return vs Industry and Market
  • IATR outperformed the Healthcare industry which returned -20.9% over the past year.
  • IATR outperformed the Market in Greece which returned 4.6% over the past year.
Price Volatility
IATR
Industry
5yr Volatility vs Market

Value

 Is Athens Medical Center undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Athens Medical Center to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Athens Medical Center.

ATSE:IATR Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 19.4%
Perpetual Growth Rate 10-Year GR Government Bond Rate 4.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for ATSE:IATR
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GR Govt Bond Rate 4.9%
Equity Risk Premium S&P Global 15%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.64
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.639 (1 + (1- 29%) (67.09%))
0.962
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.96
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 4.93% + (0.962 * 14.99%)
19.35%

Discounted Cash Flow Calculation for ATSE:IATR using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Athens Medical Center is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

ATSE:IATR DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 19.35%)
2019 19.66 Est @ 42.02% 16.47
2020 25.73 Est @ 30.89% 18.07
2021 31.68 Est @ 23.1% 18.63
2022 37.27 Est @ 17.65% 18.37
2023 42.43 Est @ 13.84% 17.52
2024 47.17 Est @ 11.17% 16.32
2025 51.55 Est @ 9.3% 14.94
2026 55.67 Est @ 7.99% 13.52
2027 59.60 Est @ 7.07% 12.13
2028 63.43 Est @ 6.43% 10.81
Present value of next 10 years cash flows €156.78
ATSE:IATR DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= €63.43 × (1 + 4.93%) ÷ (19.35% – 4.93%)
€461.59
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €461.59 ÷ (1 + 19.35%)10
€78.69
ATSE:IATR Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €156.78 + €78.69
€235.47
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €235.47 / 86.74
€2.71
ATSE:IATR Discount to Share Price
Calculation Result
Value per share (EUR) From above. €2.71
Current discount Discount to share price of €2.28
= -1 x (€2.28 - €2.71) / €2.71
16%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Athens Medical Center is available for.
Intrinsic value
16%
Share price is €2.28 vs Future cash flow value of €2.71
Current Discount Checks
For Athens Medical Center to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Athens Medical Center's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Athens Medical Center's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Athens Medical Center's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Athens Medical Center's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ATSE:IATR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in EUR €0.12
ATSE:IATR Share Price ** ATSE (2019-06-26) in EUR €2.28
Europe Healthcare Industry PE Ratio Median Figure of 61 Publicly-Listed Healthcare Companies 20.52x
Greece Market PE Ratio Median Figure of 97 Publicly-Listed Companies 15.76x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Athens Medical Center.

ATSE:IATR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ATSE:IATR Share Price ÷ EPS (both in EUR)

= 2.28 ÷ 0.12

18.37x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Athens Medical Center is good value based on earnings compared to the Europe Healthcare industry average.
  • Athens Medical Center is overvalued based on earnings compared to the Greece market.
Price based on expected Growth
Does Athens Medical Center's expected growth come at a high price?
Raw Data
ATSE:IATR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 18.37x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
5%per year
Europe Healthcare Industry PEG Ratio Median Figure of 37 Publicly-Listed Healthcare Companies 1.44x
Greece Market PEG Ratio Median Figure of 21 Publicly-Listed Companies 1.8x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Athens Medical Center, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Athens Medical Center's assets?
Raw Data
ATSE:IATR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in EUR €0.83
ATSE:IATR Share Price * ATSE (2019-06-26) in EUR €2.28
Europe Healthcare Industry PB Ratio Median Figure of 74 Publicly-Listed Healthcare Companies 1.87x
Greece Market PB Ratio Median Figure of 138 Publicly-Listed Companies 0.91x
ATSE:IATR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ATSE:IATR Share Price ÷ Book Value per Share (both in EUR)

= 2.28 ÷ 0.83

2.76x

* Primary Listing of Athens Medical Center.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Athens Medical Center is overvalued based on assets compared to the Europe Healthcare industry average.
X
Value checks
We assess Athens Medical Center's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Athens Medical Center has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Athens Medical Center expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Athens Medical Center, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
5%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Athens Medical Center expected to grow at an attractive rate?
  • Athens Medical Center's earnings growth is expected to exceed the low risk savings rate of 4.9%.
Growth vs Market Checks
  • Athens Medical Center's earnings growth is positive but not above the Greece market average.
  • Unable to compare Athens Medical Center's revenue growth to the Greece market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ATSE:IATR Future Growth Rates Data Sources
Data Point Source Value (per year)
ATSE:IATR Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 5%
Europe Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 12.5%
Europe Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.7%
Greece Market Earnings Growth Rate Market Cap Weighted Average 16.4%
Greece Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ATSE:IATR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ATSE:IATR Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-12-31 183 20 11
2018-09-30 180 17 8
2018-06-30 177 14 5
2018-03-31 173 6 4
2017-12-31 169 -2 3
2017-09-30 170 4 5
2017-06-30 170 9 7
2017-03-31 169 9 5
2016-12-31 167 10 3
2016-09-30 167 11 -4
2016-06-30 158 6 -12
2016-03-31 155 8 -18

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Athens Medical Center's earnings are expected to grow by 5% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Athens Medical Center is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ATSE:IATR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Athens Medical Center Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ATSE:IATR Past Financials Data
Date (Data in EUR Millions) EPS *
2018-12-31 0.12
2018-09-30 0.09
2018-06-30 0.06
2018-03-31 0.05
2017-12-31 0.03
2017-09-30 0.06
2017-06-30 0.09
2017-03-31 0.06
2016-12-31 0.04
2016-09-30 -0.05
2016-06-30 -0.14
2016-03-31 -0.21

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Athens Medical Center will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Athens Medical Center's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Athens Medical Center has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Athens Medical Center performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Athens Medical Center's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Athens Medical Center has delivered over 20% year on year earnings growth in the past 5 years.
  • Athens Medical Center's 1-year earnings growth exceeds its 5-year average (309.7% vs 65.1%)
  • Athens Medical Center's earnings growth has exceeded the Europe Healthcare industry average in the past year (309.7% vs 6%).
Earnings and Revenue History
Athens Medical Center's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Athens Medical Center Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ATSE:IATR Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 182.75 10.76 30.53
2018-09-30 179.88 8.08 30.06
2018-06-30 177.01 5.39 29.59
2018-03-31 173.14 4.01 28.23
2017-12-31 169.27 2.63 26.87
2017-09-30 169.68 5.05 26.17
2017-06-30 170.10 7.47 25.48
2017-03-31 168.72 5.47 25.88
2016-12-31 167.35 3.47 26.29
2016-09-30 166.84 -4.45 28.10
2016-06-30 157.53 -12.04 29.77
2016-03-31 155.31 -18.35 33.75
2015-12-31 158.09 -15.77 34.18
2015-09-30 147.12 -26.29 32.93
2015-06-30 149.76 -25.08 31.69
2015-03-31 151.08 -16.33 30.25
2014-12-31 148.87 -18.56 30.96
2014-09-30 127.07 -34.31 28.69
2014-06-30 131.25 -32.44 28.96
2014-03-31 138.79 -36.24 28.41
2013-12-31 142.38 -38.67 28.35
2013-09-30 188.97 -22.47 50.21
2013-06-30 192.52 -21.33 52.24
2013-03-31 200.22 -21.69 51.10
2012-12-31 229.51 -7.86 53.50
2012-09-30 248.48 6.94 41.19
2012-06-30 244.93 -1.72 38.37

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Athens Medical Center has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Athens Medical Center used its assets more efficiently than the Europe Healthcare industry average last year based on Return on Assets.
  • Athens Medical Center has become profitable over the past 3 years. This is considered to be a significant improvement in its use of capital (Return on Capital Employed).
X
Past performance checks
We assess Athens Medical Center's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Athens Medical Center has a total score of 5/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Athens Medical Center's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Athens Medical Center's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Athens Medical Center's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Athens Medical Center's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Athens Medical Center's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Athens Medical Center Company Filings, last reported 5 months ago.

ATSE:IATR Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 71.78 132.42 4.59
2018-09-30 71.78 132.42 4.59
2018-06-30 68.76 136.60 4.43
2018-03-31 68.76 136.60 4.43
2017-12-31 63.34 143.06 3.23
2017-09-30 63.34 143.06 3.23
2017-06-30 65.90 143.95 4.25
2017-03-31 65.90 143.95 4.25
2016-12-31 60.76 144.82 12.18
2016-09-30 60.76 144.82 12.18
2016-06-30 60.00 148.30 4.52
2016-03-31 60.00 148.30 4.52
2015-12-31 58.85 148.99 10.43
2015-09-30 64.80 151.12 2.64
2015-06-30 71.19 152.23 4.06
2015-03-31 76.94 154.44 2.89
2014-12-31 73.81 158.38 5.37
2014-09-30 91.82 156.95 3.35
2014-06-30 96.87 160.20 4.69
2014-03-31 93.87 168.75 5.40
2013-12-31 92.95 169.77 17.45
2013-09-30 126.61 170.26 6.68
2013-06-30 129.94 171.50 17.42
2013-03-31 130.78 171.91 28.88
2012-12-31 132.48 183.65 71.20
2012-09-30 144.01 169.74 7.72
2012-06-30 147.06 170.51 6.32
  • Athens Medical Center's level of debt (184.8%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (183.8% vs 184.8% today).
  • Debt is not well covered by operating cash flow (15.1%, less than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 2.5x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Athens Medical Center's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Athens Medical Center has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Athens Medical Center's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Athens Medical Center dividends.
If you bought €2,000 of Athens Medical Center shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Athens Medical Center's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Athens Medical Center's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ATSE:IATR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 46 Stocks 1.7%
Greece Market Average Dividend Yield Market Cap Weighted Average of 50 Stocks 4%
Greece Minimum Threshold Dividend Yield 10th Percentile 1.3%
Greece Bottom 25% Dividend Yield 25th Percentile 1.9%
Greece Top 25% Dividend Yield 75th Percentile 4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ATSE:IATR Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2011-11-28 0.000 0.000
2011-08-30 0.000 0.000
2011-05-25 0.000 0.000
2011-03-30 0.000 0.000
2010-03-01 0.010 1.392
2010-01-15 0.010 0.804
2009-04-30 0.050 3.221
2009-03-03 0.050 3.936
2009-01-15 0.050 4.264

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Athens Medical Center has not reported any payouts.
  • Unable to verify if Athens Medical Center's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Athens Medical Center's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Athens Medical Center has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Athens Medical Center's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Athens Medical Center afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Athens Medical Center has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Athens Medical Center's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Vassilios Apostolopoulos
CEO Bio

Dr. Vassilis G. Apostolopoulos serves as Chief Executive Officer of Athens Medical Center SA. and served as its Vice President. Dr. Apostolopoulos serves as a Director of Athens Medical Center SA. He serves as a member of the Advisory Board of the Center for International Business Managements of Cambridge University. Dr. Apostolopoulos holds a Bachelor's degree from the London School of Economics and a Master's degree in Business Administration from Cambridge University.

CEO Compensation
  • Insufficient data for Vassilios to compare compensation growth.
  • Insufficient data for Vassilios to establish whether their remuneration is reasonable compared to companies of similar size in .
Management Team

George Apostolopoulos

TITLE
President of the Board
AGE
77

Vassilios Apostolopoulos

TITLE
CEO & Executive Director

Christos Apostolopoulos

TITLE
Vice President of the Board

Petros Adamopoulos

TITLE
Chief Financial Officer

Vassilios Bardis

TITLE
Chief Operating Officer

Panagiotis Katsichtis

TITLE
Chief Accountant

Fanis Nezeritis

TITLE
Head of Technical Department

George Zerdilas

TITLE
Investor Relations Officer & Corporate Announcements Manager

Emmanouil Markopoulos

TITLE
Chief Financial Officer of Group

Theodora Nezeriti

TITLE
Legal Consultant
Board of Directors

George Apostolopoulos

TITLE
President of the Board
AGE
77

Vassilios Apostolopoulos

TITLE
CEO & Executive Director

Christos Apostolopoulos

TITLE
Vice President of the Board

Nicholas Koritsas

TITLE
Independent Non-Executive Director
TENURE
8.5 yrs

Basil Tountopoulos

TITLE
Independent Non Executive Director

Jan Ruediger

TITLE
Non Executive Director

Alexandra Mikroulea

TITLE
Independent Non Executive Director
TENURE
2.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
31. Dec 18 Buy Georgios Apostolopoulos Individual 31. Dec 18 31. Dec 18 2,000 €1.00 €2,000
19. Dec 18 Buy Georgios Apostolopoulos Individual 19. Dec 18 19. Dec 18 1,050,000 €1.00 €1,050,000
30. Oct 18 Buy Georgios Apostolopoulos Individual 30. Oct 18 30. Oct 18 1,050 €1.08 €1,134
29. Oct 18 Buy Georgios Apostolopoulos Individual 29. Oct 18 29. Oct 18 1,095 €1.06 €1,161
12. Oct 18 Buy Georgios Apostolopoulos Individual 12. Oct 18 12. Oct 18 1,763 €1.10 €1,939
11. Oct 18 Buy Georgios Apostolopoulos Individual 11. Oct 18 11. Oct 18 10,600 €1.07 €11,342
10. Oct 18 Buy Georgios Apostolopoulos Individual 10. Oct 18 10. Oct 18 1,500 €1.10 €1,650
09. Oct 18 Buy Georgios Apostolopoulos Individual 09. Oct 18 09. Oct 18 1,492 €1.10 €1,641
08. Oct 18 Buy Georgios Apostolopoulos Individual 08. Oct 18 08. Oct 18 3,000 €1.10 €3,286
03. Oct 18 Buy Georgios Apostolopoulos Individual 03. Oct 18 03. Oct 18 3,889 €1.07 €4,161
28. Aug 18 Buy Georgios Apostolopoulos Individual 28. Aug 18 28. Aug 18 1,813 €1.31 €2,375
24. Aug 18 Buy Georgios Apostolopoulos Individual 24. Aug 18 24. Aug 18 2,190 €1.31 €2,869
17. Aug 18 Buy Georgios Apostolopoulos Individual 17. Aug 18 17. Aug 18 4,737 €1.30 €6,158
23. Aug 18 Buy Georgios Apostolopoulos Individual 23. Aug 18 23. Aug 18 2,371 €1.30 €3,082
20. Aug 18 Buy Georgios Apostolopoulos Individual 20. Aug 18 20. Aug 18 150 €1.31 €196
16. Aug 18 Buy Georgios Apostolopoulos Individual 16. Aug 18 16. Aug 18 552 €1.31 €723
13. Aug 18 Buy Georgios Apostolopoulos Individual 13. Aug 18 13. Aug 18 376 €1.31 €493
09. Aug 18 Buy Georgios Apostolopoulos Individual 09. Aug 18 09. Aug 18 468 €1.31 €613
22. Aug 18 Buy Georgios Apostolopoulos Individual 22. Aug 18 22. Aug 18 9,990 €1.30 €12,987
14. Aug 18 Buy Georgios Apostolopoulos Individual 14. Aug 18 14. Aug 18 3,381 €1.30 €4,408
21. Aug 18 Buy Georgios Apostolopoulos Individual 21. Aug 18 21. Aug 18 2,477 €1.30 €3,220
06. Aug 18 Buy Georgios Apostolopoulos Individual 06. Aug 18 06. Aug 18 135 €0.01 €1
03. Aug 18 Buy Georgios Apostolopoulos Individual 03. Aug 18 03. Aug 18 6,560 €1.30 €8,537
02. Aug 18 Buy Georgios Apostolopoulos Individual 02. Aug 18 02. Aug 18 2,200 €1.30 €2,860
01. Aug 18 Buy Georgios Apostolopoulos Individual 01. Aug 18 01. Aug 18 985 €1.31 €1,290
31. Jul 18 Buy Georgios Apostolopoulos Individual 31. Jul 18 31. Jul 18 274 €1.30 €356
30. Jul 18 Buy Georgios Apostolopoulos Individual 30. Jul 18 30. Jul 18 1,600 €1.30 €2,080
27. Jul 18 Buy Georgios Apostolopoulos Individual 27. Jul 18 27. Jul 18 1,410 €1.30 €1,833
20. Jul 18 Buy Georgios Apostolopoulos Individual 20. Jul 18 20. Jul 18 751 €1.32 €991
16. Jul 18 Buy Georgios Apostolopoulos Individual 16. Jul 18 16. Jul 18 600 €1.31 €786
13. Jul 18 Buy Georgios Apostolopoulos Individual 13. Jul 18 13. Jul 18 1,299 €1.31 €1,702
12. Jul 18 Buy Georgios Apostolopoulos Individual 12. Jul 18 12. Jul 18 2,250 €1.31 €2,947
11. Jul 18 Buy Georgios Apostolopoulos Individual 11. Jul 18 11. Jul 18 1,000 €1.30 €1,300
10. Jul 18 Buy Georgios Apostolopoulos Individual 10. Jul 18 10. Jul 18 1,000 €1.30 €1,300
06. Jul 18 Buy Georgios Apostolopoulos Individual 06. Jul 18 06. Jul 18 1,586 €1.30 €2,062
29. Jun 18 Buy Georgios Apostolopoulos Individual 29. Jun 18 29. Jun 18 6,000 €1.32 €7,920
X
Management checks
We assess Athens Medical Center's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Athens Medical Center has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Who Has Been Buying Athens Medical Center S.A. (ATH:IATR) Shares?

ATSE:IATR Recent Insider Trading, June 4th 2019 Athens Medical Center is not the only stock insiders are buying. … Does Athens Medical Center Boast High Insider Ownership? … Judging from their transactions, and high insider ownership, Athens Medical Center insiders feel good about the company's future.

Simply Wall St -

Here’s What Athens Medical Center S.A.’s (ATH:IATR) Return On Capital Can Tell Us

The formula for calculating the return on capital employed is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Athens Medical Center: 0.071 = €16m ÷ (€359m - €135m) (Based on the trailing twelve months to December 2018.) Therefore, Athens Medical Center has an ROCE of 7.1%. … Athens Medical Center's Current Liabilities And Their Impact On Its ROCE Current liabilities are short term bills and invoices that need to be paid in 12 months or less. … Athens Medical Center has a medium level of current liabilities (boosting the ROCE somewhat), and a low ROCE.

Simply Wall St -

Do Directors Own Athens Medical Center S.A. (ATH:IATR) Shares?

If you want to know who really controls Athens Medical Center S.A. … Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … With a market capitalization of €147m, Athens Medical Center is a small cap stock, so it might not be well known by many institutional investors.

Simply Wall St -

Shareholders Are Thrilled That The Athens Medical Center (ATH:IATR) Share Price Increased 141%

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. … One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). … The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers)

Simply Wall St -

Can Athens Medical Center S.A. (ATH:IATR) Improve Its Returns?

With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. … To keep the lesson grounded in practicality, we'll use ROE to better understand Athens Medical Center S.A. … Our data shows Athens Medical Center has a return on equity of 7.9% for the last year.

Simply Wall St -

Why We Like Athens Medical Center S.A.’s (ATH:IATR) 14% Return On Capital Employed

Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. … What is Return On Capital Employed (ROCE)? … ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business.

Simply Wall St -

Can We See Significant Insider Ownership On The Athens Medical Center S.A. (ATH:IATR) Share Register?

The big shareholder groups in Athens Medical Center S.A. … Athens Medical Center is a smaller company with a market capitalization of €86m, so it may still be flying under the radar of many institutional investors. … See our latest analysis for Athens Medical Center

Simply Wall St -

Athens Medical Center S.A. (ATH:IATR) Insiders Increased Their Holdings

View our latest analysis for Athens Medical Center. … The Last 12 Months Of Insider Transactions At Athens Medical Center. … It's very possible they regret the purchase, but it's more likely they are bullish about the company.

Simply Wall St -

Do You Like Athens Medical Center SA (ATH:IATR) At This P/E Ratio?

We'll show how you can use Athens Medical Center SA's (ATH:IATR) P/E ratio to inform your assessment of the investment opportunity. … Athens Medical Center has a P/E ratio of 16.09, based on the last twelve months. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Simply Wall St -

What Percentage Of Athens Medical Center SA (ATH:IATR) Shares Do Insiders Own?

Every investor in Athens Medical Center SA (ATH:IATR) should be aware of the most powerful shareholder groups. … With a market capitalization of €88m, Athens Medical Center is a small cap stock, so it might not be well known by many institutional investors. … View our latest analysis for Athens Medical Center

Simply Wall St -

Company Info

Description

Athens Medical Center S.A., together with its subsidiaries, owns and operates hospital units in Greece and Romania. The company operates, organizes, and administers diagnostic and therapeutic centers, and maternity and gynecology clinics, which provide various health care services. It owns and operates 8 nursing units with a total of 1,200 beds in Athens and Thessaloniki. The company also sells medical tools and sanitary/health equipment; and provides physiotherapy and sport injury restoration/treatment, as well as parking services. Athens Medical Center S.A. was founded in 1984 and is headquartered in Athens, Greece.

Details
Name: Athens Medical Center S.A.
IATR
Exchange: ATSE
Founded: 1984
€197,758,034
86,735,980
Website: http://www.iatriko.gr
Address: Athens Medical Center S.A.
5-7 Distomou Street,
Maroussi,
Athens,
15125,
Greece
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ATSE IATR Common Bearer Shares The Athens Stock Exchange GR EUR 06. May 1992
Number of employees
Current staff
Staff numbers
2,804
Athens Medical Center employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/26 20:46
End of day share price update: 2019/06/26 00:00
Last earnings filing: 2019/04/25
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.